A retrospective multicenter to assess whether responses to PARP inhibitors differ between men with BRCA1/2 and those with ATM mutations
Latest Information Update: 20 Jan 2021
At a glance
- Drugs Olaparib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 20 Jan 2021 New trial record